Browsing by Subject "Defibrillators, Implantable"
Now showing items 1-6 of 6
-
Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
(J Am Heart Assoc, 2015-08-06)BACKGROUND: Implantable cardioverter-defibrillator (ICD) therapy is associated with improved outcomes in patients with heart failure (HF), but whether this association holds among older patients with multiple comorbid illnesses ... -
Cable externalization and electrical failure of the Riata family of implantable cardioverter-defibrillator leads: A systematic review and meta-analysis.
(Heart rhythm, 2015-06)<h4>Background</h4>The Riata class of defibrillator leads were placed under US Food and Drug Association (FDA) advisory as of November 2011 because of high rates of cable externalization (CE) and electrical failure (EF). ... -
Implant healing in experimental animal models of diabetes.
(J Diabetes Sci Technol, 2011-05-01)Diabetes mellitus is becoming increasingly prevalent worldwide. Additionally, there is an increasing number of patients receiving implantable devices such as glucose sensors and orthopedic implants. Thus, it is likely that ... -
Isolated Noncompaction of the Left Ventricle in Adults.
(J Am Coll Cardiol, 2015-08-04)Isolated left ventricular noncompaction (ILVNC) is a cardiomyopathy that was first described in 1926 as a "spongy myocardium." The disorder results from intrauterine arrest of compaction of the loose interwoven meshwork ... -
Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis.
(Journal of cardiovascular electrophysiology, 2015-02)<h4>Introduction</h4>Riata and Riata ST implantable cardioverter-defibrillator (ICD) leads (St. Jude Medical, Sylmar, CA, USA) can develop conductor cable externalization and/or electrical failure. Optimal management of ... -
Use of cardiac implantable electronic devices in older adults with cognitive impairment.
(JAMA Intern Med, 2014-09)